Organoid platinum-resistance model identifies KRT17 as a biomarker of targeted therapy in ovarian cancer. - Reichenbach J; Schmid J; Hierlmayer S; Zhang T; Piga I; Geweniger S; Fischer J; Davesar A; Vasovic N; Chelariu-Raicu A; Kraus F; Burges A; et al. (IScience, 2025)